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The choice of laboratory animal diet for
rodent studies to determine the endocrine-
disrupting potential of chemicals is currently
under intense scrutiny (Lawton 2003; Odum
et al. 2001; Owens et al. 2003; Owens and
Koëter 2003; Thigpen et al. 2003). This is
because the diet selected can affect both assay
control values and assay sensitivity; for exam-
ple, uterine weight in control animals needs
to be low to maximize the dynamic range of
the uterotrophic assay. One contributing fac-
tor is the phytoestrogen content of the diet.
Most of the commonly used laboratory ani-
mal diets are formulated with soy extracts,
which contain the isoflavones genistein
(GEN) and daidzein, and/or alfalfa (lucerne),
which contains coumestrol (Patisaul and
Whitten 1999). These phytoestrogens are
estrogenic to rodents, causing effects such as
increased uterine weight and advanced vagi-
nal opening (VO) in immature animals, simi-
lar to effects observed with xenobiotic
estrogens (Bickoff et al. 1962; Boettger-Tong
et al. 1998; Casanova et al. 1999; Medlock
et al. 1995; Thigpen et al. 1999; Tinwell
et al. 2000; Whitten et al. 1992).
An analysis conducted as part of the recent
Organisation for Economic Co-operation and
Development (OECD) evaluation of the
immature rat uterotrophic assay indicated that
isoflavone levels greater than 325–350 mg
GEN equivalents/kg diet should be avoided to
maintain optimal assay sensitivity and dynamic
range (Owens et al. 2003). The phytoestrogen
content of diets is not, however, the only factor
of importance. This is shown by our earlier
demonstration that the phytoestrogen-rich diet
Purina 5001 (Purina Mills, Inc., Richmond,
IN, USA) and the phytoestrogen-free diet
AIN-76A are equally uterotrophic to rodents,
compared with the standard diet RM1, and
that each is able to advance the mean day of
VO in rats, again compared with RM1
(Odum et al. 2001). Further, we showed that
coadministration of the gonadotrophin-
releasing hormone (GnRH) antagonist
Antarelix (ANT; Europeptides, Argenteuil,
France) abolished the uterotrophic activity of
both diets, indicating that these effects were
mediated at the level of the hypothalamus to
influence GnRH secretion (Odum et al.
2001). ANT is a synthetic peptide that was
shown to be a GnRH antagonist in several ani-
mal models, including suppression of ovula-
tion in rats and leutinizing hormone release in
rams (Deghenghi et al. 1993). In a related
series of experiments, we observed a correlation
between the quantity of infant formula (IF)
consumed by immature rats and mice and the
magnitude of the resultant uterotrophic effect
(Ashby et al. 2000). The uterotrophic effects
were independent of the phytoestrogen con-
tent of the IF because they were abolished by
inhibition of GnRH with ANT. In contrast,
the uterotrophic effect of the reference syn-
thetic estrogen diethylstilbestrol (DES) was
unaffected by ANT (Ashby et al. 2000).
These findings suggest that the type of food
consumed by female rodents could inﬂuence
the time of their puberty but that these inﬂu-
ences were independent of phytoestrogen
intake at the levels present in the foods used
in these studies.
Energy intake is known to affect the onset
of puberty in mammals; for example, pigs and
rats with inadequate nutrition have retarded
sexual development (Frisch et al. 1975;
Kirkwood et al. 1987; Trentacoste et al.
2001). Energy balance in mammals is con-
trolled by a series of complex central mecha-
nisms that allow adaptive responses to
situations of energy abundance or insuffi-
ciency. Two of the key hormones are leptin
and ghrelin, which act as signals at either end
of the spectrum (Zigman and Elmquist 2003).
Leptin is secreted by adipocytes in response to
increased food intake and energy balance. Its
action on the brain and peripheral tissues
results in activation of pathways suppressing
food intake and increasing energy expenditure
(Friedman and Halaas 1998). Ghrelin is
released from endocrine cells in the stomach
in response to decreased food intake and has
the opposite effect to leptin (Gualillo et al.
2003). A deﬁnitive role for leptin in the onset
of puberty has not yet been demonstrated
(Ahima et al. 1977; Cunningham et al. 1999),
but the importance of energy balance in sexual
development led us to consider whether the
effects described previously (Odum et al.
2001) were associated with the metabolizable
energy (ME) of the diets/formulas evaluated
and hence energy intake during the prepuber-
tal period. However, the range of the ME
densities of the diets used was small, and no
useful correlation was found (Odum et al.
2001). Subsequently, Thigpen et al. (2002,
2003) evaluated several proprietary rodent
diets containing phytoestrogens and with a
wider range of ME densities. They observed a
primary correlation of the phytoestrogen level
of the diet, and a secondary correlation of the
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Laboratory animal diets for studies to determine the endocrine-disrupting potential of chemicals
are under scrutiny because they can affect both assay control values and assay sensitivity. Although
phytoestrogen content is important, we have previously shown that a phytoestrogen-rich diet and a
phytoestrogen-free diet were equally uterotrophic to rats and advanced vaginal opening (VO) when
compared with the standard diet RM1. Abolition of the effects by the gonadotrophin-releasing hor-
mone antagonist Antarelix indicated that these effects were mediated through the hypothalamus–
pituitary–reproductive organ axis. In the present study, we investigated the relationship between
cumulative energy intake and sexual maturation in female rats. Infant formula (IF) at different con-
centrations and synthetic diets, with a wide range of metabolizable energy (ME) values, were used
to modulate energy intake. Increasing energy intake was associated with an increase in uterine
weight (absolute and adjusted for body weight) for both IF and the synthetic diets. In both cases,
the increased uterine weight was directly proportional to energy intake. Body weight was unaffected
by IF consumption but, in the case of the diets, was increased proportionally with energy consump-
tion. Antarelix abolished the uterine weight increases with both formula and the diets, whereas
body weight was unaffected. The mean day of VO was also advanced by high-ME diets and IF,
whereas body weight at VO was unaffected. VO occurred at an energy intake of approximately
2,300 kJ/rat determined by measuring total food intake from weaning to VO, indicating that this
cumulative energy intake was the trigger for puberty. ME is therefore a critical factor in the choice
of diets for endocrine disruption studies. Key words: energy intake, metabolizable energy, phyto-
estrogens, puberty, soy, uterotrophic assay. Environ Health Perspect 112:1472–1480 (2004).
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VO activity of the diet to immature mice.
However, food intake by the mice was not
monitored, and this precluded accurate assess-
ments of energy intake. Further, the analysis
was complicated by studying concomitant dif-
ferences in both dietary phytoestrogen levels
and dietary ME values.
In the present experiments, we have inves-
tigated the relationship between total (cumu-
lative) energy intake and sexual maturation in
female rats. Two types of dietary modiﬁcation
were used. In one, IF (at different concentra-
tions) and sugar solutions were used to modu-
late metabolic energy intake. In the second,
open-formula synthetic phytoestrogen-free
diets, with a wide range of metabolizable
energies (8–22 kJ/g), were evaluated. Some
experiments were conducted in the presence
and absence of ANT to evaluate of the role of
the hypothalamus–pituitary–reproductive
organ axis on the effects observed.
Materials and Methods
Chemicals. DES (> 99% pure), glucose,
sucrose, and arachis oil (AO) were obtained
from Sigma Chemical Co. (Poole, Dorset,
UK). ANT was a gift from Europeptides, a
Division of Asta Medica (Argenteuil, France).
GEN was obtained from ChemService (West
Chester, PA, USA). Halothane anesthetic was
obtained from AstraZeneca (Alderley Park,
Cheshire, UK).
Animals. Alpk:APfSD (Wistar-derived)
rats, obtained from the AstraZeneca breeding
unit (Alderley Park, Macclesﬁeld, UK), were
used in all studies. Studies were performed in
accordance with the U.K. Animals (Scientiﬁc
Procedures) Act (1986). Animal care and
procedures were carried out according to
in-house standards as described previously
(Odum et al. 2001).
In the uterotrophic assays with IF and glu-
cose, we used rats that were postnatal days
(PND)21–22 on arrival into the laboratory
(where birth is PND0). In the uterotrophic
assays with the synthetic diets, we used wean-
ling rats on PND18–19. This was because the
former studies were carried out using the speci-
ﬁcations described by Odum et al. (1997), and
the latter studies followed the specifications
required by the OECD evaluation of the
uterotrophic assay (Kanno et al. 2003a,
2003b). Control uterine blotted weights for
both series of studies were similar, generally
between 20 and 30 mg. The sexual maturation
study with IF was carried out in weanling rats
on PND21–22 on arrival in the laboratory,
whereas the study with the synthetic diets used
weanling rats that were PND18–19 on arrival.
To avoid confounding effects due to litter-
mates or initial body weights, the weanling rats
were taken from multiple litters and were ran-
domly allocated to groups such that the initial
group mean body weights were similar within
experiments. In all experiments, animals were
weaned on RM3 diet (Special Diet Services
Ltd., Witham, Essex, UK) in the breeding unit
and then fed the appropriate test diet upon
arrival at the laboratory and for the duration of
the assay. All solid diets, ﬂuid diets, and drink-
ing water solutions were available ad libitum.
IF and sugar drinks. IF (Infasoy; Cow
and Gate, Trowbridge, Wiltshire, UK) was
purchased from several outlets in Cheshire
and Staffordshire (UK). It was prepared
according to manufacturer instructions using
sterile deionized water (considered as 100%
strength throughout). The basic constituents
are shown in Table 1. In one study, a dilute
solution (33% recommended strength) and a
more concentrated solution (200%) of IF
were used. A glucose (6.6% wt/vol) solution
in water was similarly prepared and evaluated.
All drinking water solutions were prepared
and replaced on a daily basis.
Diets. Two proprietary natural ingredient
diets, Rat and Mouse No. 3 (RM3) and Rat
and Mouse No. 1 (RM1) were supplied by
Special Diet Services Ltd. (Witham, Essex,
UK). RM1 has been consistently used as the
standard diet in our postweaning studies since
1997 (Odum et al. 2001). A series of open-
formula synthetic diets with a range of MEs
(diets A–E) were produced by Harlan Teklad
UK (Bicester, Oxfordshire, UK) and were
based on AIN-76A (Knapka 1983). The con-
stituents and proportions for all diets used, as
well as the unique Harlan Teklad reference
numbers for diets A–E, are listed in Table 1.
AIN-76A and RM1 were included to provide
links to our previous findings (Odum et al.
2001). In order to derive a wide range of ME
densities, a base diet (designated diet B) was
created. Diets with increasing ME densities
were then achieved by substituting increasing
proportions of lard for cellulose (diets C–E).
A diet with an additional decrease in ME
(diet A) was obtained by reducing the propor-
tion of sucrose and maltodextrin. All diets
were prepared as pellets. 
We estimated ME densities of the syn-
thetic diets using the values for protein, fat,
and carbohydrate given by Blaxter (1989).
The figure for casein protein takes into
account the fact that it contains 10% mois-
ture and 1% fat. The energy in the minerals
and vitamins was derived from the excipients.
Protein, vitamins, and fatty acids were main-
tained at a constant level in all the diets. The
diets lowest in fat contained sufﬁcient essen-
tial fatty acids to meet normal dietary require-
ments. The values for RM1 and IF were as
reported by the manufacturer (Table 1). Total
ME intake over the duration of the studies
was calculated from solid and liquid food
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Table 1. Composition and ME content of the diets.
Diets A–E (%)
RM1a IF (Infasoy)b AIN-76A A B C D E
Constituent g/100 g Constituent g/100 mL Constituent g/100 g Constituent 02171c 01364 01365 02332 01366
Wheat/barley/wheat 88.5 Glucose  syrup  NS Casein 20 Casein 20 20 20 20 20
middlings Carbohydrates 6.7 Sucrose 50 Sucrose 17.5 32.5 32.5 32.5 27.5
Soybean meal  6.0 Vegetable oils NS Corn starch 15 Maltodextrin 5 15 15 15 15
Whey powder 2.5 Fat 3.6 Cellulose 5 Cellulose 50 25 13.75 2.5 0
Soy oil 0.5 Soy protein isolate NS Corn oil 5 Lard 2.5 2.5 13.75 25 32.5
Minerals Minerals 0.4 Minerals 3.5 Minerals 3.5 3.5 3.5 3.5 3.5
Vitamins 2.5 Vitamins Vitamins 1 Vitamins 11111
Amino acids DL-Methionine 0.3 DL-Methionine 0.3 0.3 0.3 0.3 0.3
Choline 0.2 Choline 0.2 0.2 0.2 0.2 0.2
Ethoxyquin 0.001 Ethoxyquin 0.001 0.001 0.001 0.001 0.001
Total protein content  14.7 Total protein 1.8 Total protein 20 Total protein 20 20 20 20 20
(% wt/wt) content (% wt/vol) content (% wt/wt) (% wt/wt)
Total ME  10.9 Total ME  2.8 Total MEd 15.7 Total MEd 8.2 12.1 16.2 20.3 22.3
(kJ/g diet) (kJ/g diet) (kJ/g diet) (kJ/g diet)
aAll values for RM1 are as stated on the manufacturer’s data sheet. bMajor constituents as stated on the Infasoy packaging; the quantities of glucose syrup, vegetable oils, and soy pro-
tein isolate were not speciﬁed (NS), but proportions of carbohydrates, fat, and protein were given. cUnique Harlan Teklad reference numbers of the synthetic diets. dME was calculated
using the following values (kJ/g constituent): casein, 16 kJ/g; sucrose, 16 kJ/g; corn starch, 16 kJ/g; maltodextrin, 16 kJ/g; cellulose, 0.3 kJ/g; corn oil, 37 kJ/g; lard, 37 kJ/g; minerals,
1.9 kJ/g; vitamins, 15.7 kJ/g; DL-methionine, 17 kJ/g; choline, 0 kJ/g; ethoxyquin, 0 kJ/g. The composition of the synthetic diets A–E was based on that of AIN-76A such that the protein
content was identical but the carbohydrate and fat content were adjusted to give varying total ME values.consumption data and the ME content of the
diets and drinks.
Analysis of diets for phytoestrogens. We
analyzed IF for daidzein and GEN content
using the method described previously by
Odum et al. (2001) and Owens et al. (2003).
The limits of detection were 0.1 µg/g diet.
The phytoestrogen aglycone contents of diet B
(as representative of the phytoestrogen-free
synthetic diets A–E) and RM1 were deter-
mined as described in detail by Wiseman et al.
(2002). Portions of the diet (200 mg) were
extracted by shaking with aqueous methanol
at 60°C for 1 hr. The extracts were defatted
with hexane and hydrolyzed to the aglycones
with dilute hydrochloric acid. The aglycones
were then extracted with ether. Daidzein,
GEN, glycitein, and coumestrol were detected
and quantified against reference samples by
liquid chromatography coupled with mass
spectroscopy. Data were adjusted for extrac-
tion efficiency. Quality control was deter-
mined by the concurrent analysis of a soy ﬂour
of known daidzein and GEN content, and
results were < 9% different from those
expected. The limit of detection was 0.05 µg/g
diet for daidzein, GEN, and glycitein and
0.1 µg/g diet for coumestrol.
Animal studies. In all experiments, wean-
ling rats were fed IF or synthetic diets upon
arrival in the laboratory. Uterotrophic assays
were based on the protocol described by
Kanno et al. (2003a, 2003b) where the basic
end point is uterine weight. In the sexual
maturation studies, dietary modulation con-
tinued from weaning to postpuberty, and end
points related to puberty (e.g., VO) were
monitored. A scheme of the experiments and
the hypotheses that they were designed to
address are shown in Table 2.
Uterotrophic assays. Uterotrophic assays
were conducted using IF at different concen-
trations selected to provide a concentration-
dependent response (experiments 1 and 2). In
experiment 3, we administered a 6.6% glu-
cose solution, either alone or in addition to
coadministration of 5 mg/kg body weight
GEN. In these experiments, the normal drink-
ing water supply was replaced with either IF or
glucose solutions. RM1 was provided as an
optional solid food. Control rats were fed
RM1 and water. Three uterotrophic assays
were conducted using the pelleted synthetic
diets (experiment 4 of 4 days’ duration and
experiments 5 and 6 of 6 days’ duration).
Control rats were fed RM1. Rats were housed
up to ﬁve per cage. Food and ﬂuid were avail-
able ad libitum and monitored (by cage) daily.
In experiments 1, 4, and 6, the GnRH
antagonist ANT was coadministered at a dose
of 300 µg/kg/day by subcutaneous (sc) injec-
tion (dosing volume, 1.5 mL/kg; Odum et al.
2001). In experiment 3, GEN was coadminis-
tered orally at 5 mg/kg/day in AO (dosing vol-
ume, 5 mL/kg). DES was used as a positive
control in all studies. In experiments 1–3,
DES was administered in the drinking water
at either 10 or 20 µg/L, starting on the day of
arrival of the rats at the laboratory and contin-
uing throughout the experiment. In experi-
ments 4–6, it was administered by sc injection
at 5 µg/kg/day with a dosing volume of
1.5 mL/kg. Some animals received both DES
and ANT or DES and AO, administered by
two successive sc injections made within
5 min of each other. Rats administered DES
were fed RM1. Control animals received vehi-
cle only. Dosing of compounds (by sc or oral
routes) commenced on the day after the rats
had been placed on the test diets and contin-
ued daily. Animals were killed by an overdose
of halothane 24 hr after the final chemical
administration. Uteri were removed, blotted,
and weighed as described previously (Odum
et al. 1997).
Sexual maturation studies. Weanling rats
were provided with IF solutions, in place of
drinking water supply, and RM1 diet in
experiments 7 and 8. In experiment 9, wean-
ling rats were fed either diet B or diet D
instead of RM1. Control animals were fed
RM1 in all experiments. Experiment 7 also
contained a group of “heavy” control animals
consisting of a group of the heaviest animals
selected from the required weight range.
Consequently, in the sexual maturation stud-
ies, the initial weights of the standard RM1
control group and the IF group were similar,
whereas the weight of the “heavy control
group” was greater. DES (30 µg/L in the
drinking water) was administered in experi-
ment 9 as a positive control with RM1 as the
diet. This concentration of DES has previ-
ously been shown to decrease the mean age at
VO by 7 days in the absence of changes in
body weight (Odum et al. 2002). All diets and
drinking water were available ad libitum. Rats
in experiment 7 were housed singly, whereas
rats in experiments 8 and 9 were housed in
groups of five. Food and fluid consumption
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Table 2. Experimental scheme and hypotheses.
Experiment Hypothesis Treatment Duration
Uterotrophic studies
Experiment 1 IF consumption increases uterine weight IF, ANT,a DESb 4 days (PND21–25)
ANT antagonizes IF-induced uterine weight 
increase
ANT does not antagonize DES-induced uterine 
weight increasec
Experiment 2 IF-induced uterine weight increase is dependent  IF (33–200%), DES 4 days (PND21–25)
on IF concentration
Experiment 3 Glucose and GEN increase uterine weight Glucose, GEN, DES 4 days (PND21–25)
Experiment 4 Consumption of synthetic diets with higher ME  Synthetic diets,  4 days (PND18–22)
than RM1 increases uterine weight over 4 days ANT, DES
ANT antagonizes synthetic diet-induced uterine
weight increase
ANT does not antagonize DES-induced uterine
weight increase
Experiment 5 Consumption of synthetic diets with higher ME  Synthetic diets, DES 6 days (PND18–24)
than RM1 gives greater uterine weight 
increase over 6 days
Experiment 6 Consumption of synthetic diets with low–high  Synthetic diets,  6 days (PND18–24)
ME range shows correlation of ME with  ANT, DES
uterine weight
ANT antagonizes synthetic diet-induced uterine
weight increase
ANT does not antagonize DES-induced uterine
weight increase
Sexual maturation studies
Experiment 7 IF consumption reduces age at VO IF 20 days (PND21–41)
Age-matched heavy controls have earlier VO
Experiment 8 IF consumption reduces age at VO and age at  IF  97 days (PND21–118)
ﬁrst and second estrus
Energy intake after weaning determines age
at VO
Experiment 9 Consumption of synthetic diets with higher  Synthetic diets,  23 days (PND18–41)
ME than RM1 reduces age and body weight ANT, DES
at VO
Energy intake after weaning determines age
at VO
DES treatment reduces age and body weight
at VOd
Experiment 9 Consumption of synthetic diets affects organ  Synthetic diets,  23 days (PND18–41)
weight DES
aANT is a GnRH antagonist used to determine whether GnRH mediates uterine weight increases. bDES was used through-
out as a positive control. cAs demonstrated previously (Ashby et al. 2000). dAs demonstrated previously (Odum et al. 2002).were monitored daily. VO was monitored
daily from PND21, and individual body
weights on the day of VO were recorded.
The age at first and second estrus were
determined in experiment 8 by analysis of daily
vaginal smears that were taken from the day of
VO to PND65. First estrus was deﬁned as the
ﬁrst day on which only corniﬁed epithelial cells
were observed on the vaginal smear. Second
estrus was deﬁned as the day on which a smear
indicating estrus fell within a run of smears
clearly showing the correct cyclic sequence of
proestrus, estrus, metestrus, and diestrus.
Animals were killed on PND41, when all
animals had open vaginas (experiments 7
and 9), or PND118, after second estrus
(experiment 8). Liver, kidney, and uterine
weights were determined at necropsy.
Statistical methods. For uterotrophic
assays, we analyzed uterine weights by covari-
ance with the terminal body weights. Terminal
body weights were analyzed by covariance with
initial body weights. Differences from control
values (RM1 or RM1 with AO, as appropriate)
were assessed statistically using a two-sided
Student’s t-test based on the error mean square
from the analysis of covariance (ANCOVA).
Relationships between energy intake and body
or uterine weight were analyzed by linear
regression.
For sexual maturation studies, analysis of
variance (ANOVA) was carried out on body
weights, food consumption, and organ weights.
Organ weights were also analyzed by covariance
with the terminal body weights (Shirley 1996).
VO was analyzed by Fisher’s exact test on the
proportions of animals recorded each day with
VO and by ANOVA for the observed days of
VO and body weights at the time of VO.
Differences from control values in all cases
were assessed statistically using a two-sided
Student’s t-test based on the error mean square
from the ANOVA or ANCOVA. Analyses
were carried out with SAS software (Version 8;
SAS Institute, Inc., Cary, NC, USA).
Results
Diet analyses. The synthetic diets A–E were
free from daidzein, GEN, glycitein, and
coumestrol. RM1 contained low levels of the
phytoestrogens daidzein, GEN, and glycitein
(11, 9, and 2 µg/g diet, respectively) and non-
detectable levels of coumestrol. IF contained
45.7 µg daidzein and 133.4 µg GEN per gram
dry formula (glycitein and coumestrol were
not analyzed). ME values for the diets and IF
are shown in Table 1.
Uterotrophic assays. In experiments 1
and 2 (Table 3), IF gave a positive uterotrophic
response except when 33% IF was used
(experiment 2, Table 3). All increases in uter-
ine weight (compared with RM1 controls)
occurred without significant effects on final
body weights, except for the 200% IF group
(Table 3). Energy intake was also increased
above the RM1 controls in animals consuming
IF. In experiment 2, uterine weight was
increased proportionally with increasing IF
concentration and energy intake (Figure 1).
Coadministration of the GnRH antagonist
ANT abolished the uterine weight increases
induced by IF but did not affect the response
given by DES (experiment 1, Table 3;
Figure 2).
Administration of a solution of glucose to
rats in 4-day uterotrophic assays (experiment 3,
Table 3) had no effect on uterine weight. The
concentrations were chosen based on the pres-
ence of 6.6% glucose in IF. Uterine weight was
also unaffected by GEN at 5 mg/kg/day; this
was the calculated daily intake of isoﬂavone in
human infants consuming IF (at 100% con-
centration). The lack of effect is as expected
from the dose response of GEN in the
uterotrophic assay (Kanno et al. 2003a).
The results of the uterotrophic assays with
the synthetic diets are shown in Tables 4
and 5. In all cases, uterine wet weight increased
as energy intake increased in animals fed the
synthetic diets. Body weights also increased,
but uterine weights adjusted for covariance
with terminal body weights were still increased.
In experiment 4, rats were fed diets B–D
and AIN-76A for 4 days, and the energy con-
tent of the synthetic diets ranged from 12.1 to
20.3 kJ/g. Absolute and adjusted uterine weight
was signiﬁcantly increased from 21 mg (RM1
control) to a maximum of approximately
35 mg by all the synthetic diets. The increase
was abolished by coadministration of the
GnRH antagonist ANT, when all diet groups
attained absolute uterine weights of 17–19 mg
(Table 4, Figure 2). Coadministration of ANT
to the DES group had no effect on uterine
weight (Figure 2). In experiment 5, the dura-
tion of the experiment was increased to 6 days
in an attempt to enhance the sensitivity of the
assay. Absolute and adjusted uterine weights
for rats consuming diets B–D were signifi-
cantly increased to a maximum of approxi-
mately 48 mg, and energy consumption was
increased concomitantly (Table 5). In experi-
ment 6, two more diets (diets A and E) were
evaluated, expanding the ME range to
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Table 3. Immature rat uterotrophic assays with IF and sugar drinks (experiments 1–3).
Total energy Percent energy Absolute uterine Adjusted uterine Final body
Experiment/treatment intake (kJ)a/rat intake as drink blotted weight (mg)b blotted weight (mg)c weight (g)b No.
Experiment 1
RM1 238 0 20.7 ± 2.8  20.4 52.3 ± 4.5 10
RM1, IF 100% 416 88 29.9 ± 4.9** 29.8** 53.8 ± 3.3 10
RM1, DES 10 µg/L 243 0 41.8 ± 11.9** 41.6** 53.8 ± 4.1 10
RM1, ANT 237 0 16.3 ± 1.5 16.0 52.7 ± 4.1 10
RM1, IF 100%, ANT 431 89 16.9 ± 1.1 16.7 56.1 ± 3.7 10
RM1, DES 10 µg/L, ANT 254 0 39.7 ± 13.8# 39.5# 52.8 ± 4.4 10
Experiment 2
RM1 311 0 27.3 ± 4.6  28.0 62.1 ± 5.4 9
RM1, IF 33% 341 22 31.5 ± 5.2 32.4 61.8 ± 5.8 10
RM1, IF 100% 464 62 40.7 ± 11.6** 40.5** 63.3 ± 5.2 10
RM1, IF 200% 547 75 44.7 ± 16.2** 43.3** 64.9 ± 5.3* 10
RM1, DES 10 µg/L 321 0 40.7 ± 6.0** 39.3** 65.0 ± 4.5 5
Experiment 3
RM1, AO 222 0 22.2 ± 5.8 23.3 54.5 ± 6.4 9
RM1, glucose 6.6% 333 19.6 22.0 ± 6.0 22.7 55.2 ± 7.2 9
RM1, GEN 5 mg/kg/day ND 0 21.3 ± 2.4 21.1 56.6 ± 7.4 9
RM1, glucose 6.6%,  253 22.6 23.9 ± 5.9 24.8 54.8 ± 7.3 9
GEN 5 mg/kg/day
RM1, DES 20 µg/L 239 0 73.9 ± 15.3** 73.0** 57.8 ± 6.4 9
ND, not determined. DES was administered in drinking water. 
aTotal energy intake was calculated from the total amount of liquid and solid food consumed per rat over the duration of the study and their MEs. The ME value for RM1 was taken from
the manufacturer’s data sheet; the ME value of IF was taken from information supplied by the manufacturer and adjusted for concentration where necessary; and the ME value of
16 kJ/g for glucose/sucrose was adjusted for concentration. bMean ± SD. cUterine weights adjusted for covariance with terminal body weights. *p < 0.05 and **p < 0.01 compared with
RM1 or RM1/AO control. #p < 0.01 compared with RM1/ANT control.8.2–22.3 kJ/g. Diets were also fed for 6 days.
The body weight curves (Figure 3) display a
clear relationship between increasing energy
intake and body weight, with body weights of
animals fed diets B, C, D, and E being signiﬁ-
cantly increased relative to the RM1 control.
Total energy intake over the 6 days was pro-
portional to the ME of the diets (Figure 4).
Coadministration of ANT had no effect on
body weight (Table 5). Absolute and adjusted
uterine weights were again significantly
increased in animals fed the synthetic diets
B–E compared with those fed RM1. In ani-
mals receiving diet A, with the lowest ME,
absolute uterine weight was not significantly
increased, but the increase in adjusted uterine
weight was signiﬁcant. A plateau was reached at
absolute uterine weights of approximately
50–55 mg, suggesting that this may be the limit
of prepubertal stimulation of uterine growth by
manipulation of energy intake (Table 5). ANT
again abolished the increases in uterine growth,
reducing all absolute uterine weights to
16–19 mg (Table 5). The relationship between
energy intake and either final body weight,
absolute uterine weight, or uterine weight
adjusted for body weight, for the data from
experiment 6 (Table 5), was analyzed by linear
regression (Figure 5).
In the uterotrophic assays with synthetic
diets, the SDs for uterine weights were gener-
ally at least double those obtained with RM1.
The reason for this is not clear. When ANT
was coadministered, the SDs for uterine weight
were smaller and less variable. We carried out
an experiment in which rats were fed diet D
under conditions of both single and group
housing—in case competition for food within
the cage was a factor—but SDs in both cases
were similarly large (data not shown). We also
attempted to reduce the uterine weight of rats
fed diet D to that of rats fed diet B by restrict-
ing food (and therefore caloric) intake. The
restriction achieved, however, was only partial
because the animals ate their allocated amount
of diet D so quickly that they would have been
without food for long periods of the night.
This was considered to be unacceptable for our
animal license, and therefore the rats were
given more food. A total energy intake of
Article | Odum et al.
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Figure 1. Total energy intake for rats drinking IF
(33%, 100%, or 200% solutions) shown plotted
against the increase in uterine weight above con-
trol levels (RM1 diet and water; all animals had
access to RM1 diet). R2 = 0.99, p < 0.01. Data are
based on experiment 2 (Tables 2 and 3). 
aUterine weight increase not signiﬁcant. **Uterine weight
increase signiﬁcant at p< 0.01
Figure 2. The effect of ANT (0.3 mg/kg/day, sc) on
adjusted blotted uterine weights of rats fed IF or
synthetic diets or dosed with DES [10 µg/L in drink-
ing water (experiment 1) or 5 µg/kg/day sc (experi-
ment 4)] in 4-day immature rat uterotrophic assays
(Tables 3 and 4, respectively). Values are ANCOVA-
adjusted means.
**p < 0.01 compared with RM1 control. #p < 0.01 compared
with RM1/ANT control.
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Table 5. Immature rat uterotrophic assays (6 days’ duration) using synthetic diets of different ME content
(experiments 5 and 6).
Diet ME Total energy Absolute  Adjusted 
intake intake uterine blotted uterine blotted Final body
Experiment/treatment (kJ/g diet)a (kJ)b/rat weight (mg)c weight (mg)d weight (g)c No.
Experiment 5
RM1 10.9 485 27.6 ± 3.1 31.0 57.7 ± 6.5 10
Diet B 12.1 483 36.6 ± 6.7* 40.2** 57.5 ± 5.1 10
AIN-76A  15.7 696 45.0 ± 12.4** 42.1** 66.4 ± 5.1** 10
Diet C 16.2 666 44.7 ± 7.2** 42.9** 64.9 ± 5.8** 10
Diet D 20.3 907 47.5 ± 8.3** 42.0** 70.0 ± 6.4** 10
RM1/AO 10.9 471 30.4 ± 4.0 38.1 51.8 ± 8.2** 10
RM1/DES 5 µg/kg 10.9 530 131.2 ± 18.0** 133.9** 60.3 ± 5.6** 4
Experiment 6
RM1/AO 10.9 520 26.4 ± 5.3 29.3 62.3 ± 5.4 10
Diet A/AO 8.2 426 33.2 ± 6.7 36.9* 61.0 ± 6.8 10
Diet B/AO 12.1 555 39.7 ± 7.8** 39.8** 66.5 ± 7.0* 10
Diet C/AO 16.2 897 50.8 ± 16.2** 49.0** 69.3 ± 5.0** 10
Diet D/AO 20.3 1,010 55.6 ± 18.6** 51.9** 72.2 ± 5.5** 10
Diet E/AO 22.3 481 50.9 ± 15.4** 48.0** 71.0 ± 4.1** 10
RM1/DES 5 µg/kg 10.9 434 122.4 ± 17.2** 124.6** 60.7 ± 6.3 4
RM1/ANT 10.9 493 16.1 ± 1.2 20.1 60.6 ± 4.6 10
Diet A/ANT 8.2 408 17.4 ± 1.5 22.6 58.9 ± 5.6# 10
Diet B/ANT 12.1 816 18.6 ± 2.1 21.5 62.3 ± 8.6 10
Diet C/ANT 16.2 314 19.2 ± 1.5 14.9 72.9 ± 6.3# 10
Diet D/ANT 20.3 991 18.4 ± 1.9 15.6 70.9 ± 5.1# 10
Diet E/ANT 22.3 1,131 19.1 ± 2.6 14.7 73.1 ± 6.9# 10
RM1/DES 5 µg/kg/ANT 10.9 465 153 ± 20.8# 154.5# 58.7 ± 2.7 4
DES was administered subcutaneously.
aThe ME value for RM1 was taken from the manufacturer’s data sheet. bTotal energy intake was calculated as the prod-
uct of the total amount of food consumed per rat over the duration of the study and the ME of the diet. cMean ± SD.
dUterine weights adjusted for covariance with terminal body weights. *p < 0.05 and **p < 0.01 compared with RM1 or
RM1/AO control. #p < 0.01 compared with RM1/ANT control.
Table 4. Immature rat uterotrophic assays (4 days’ duration) using synthetic diets of different ME content
(experiment 4).
Diet ME Total Absolute  Adjusted
intake energy intake uterine blotted uterine blotted Final body
Treatment (kJ/g diet)a (kJ)b/rat weight (mg)c weight (mg)d weight (g)c No.
RM1/AO 10.9 222 21.4 ± 3.2 22.4 51.2 ± 7.2 10
Diet B/AO 12.1 243 29.2 ± 7.4** 30.7** 50.0 ± 8.0 10
AIN-76A /AO 15.7 325 35.8 ± 6.4** 34.9** 55.8 ± 8.0** 10
Diet C/AO 16.2 316 34.7 ± 9.1** 34.5** 54.0 ± 7.8** 10
Diet D/AO 20.3 218 34.4 ± 5.6** 32.5** 58.2 ± 7.6** 10
RM1/DES 5 µg/kg 10.9 434 105.1 ± 3.4** 106.1** 51.3 ± 6.6 4
RM1/ANT 10.9 222 17.1 ± 1.9 18.5 50.0 ± 6.8 10
Diet B/ANT 12.1 227 17.3 ± 2.4 18.8 49.8 ± 7.8 10
AIN-76A /ANT 15.7 336 17.8 ± 1.2 17.0 55.6 ± 6.4# 10
Diet C/ANT 16.2 314 18.1 ± 2.0 18.3 53.2 ± 8.3# 10
Diet D/ANT 20.3 422 18.8 ± 2.2 16.9 58.3 ± 6.5# 10
RM1/DES 5 µg/kg/ANT 10.9 232 119.2 ± 7.3# 120.6# 49.6 ± 7.5 4
ND, not determined. DES was administered sc.
aThe ME value for RM1 was taken from the manufacturer’s data sheet. bTotal energy intake was calculated as the prod-
uct of the total amount of food consumed per rat over the duration of the study and the ME of the diet. cMean ± SD.
dUterine weights adjusted for covariance with terminal body weights. **p < 0.01 compared with RM1 or RM1/AO control.
#p < 0.01 compared with RM1/ANT control.889 kJ over 6 days was achieved in restricted
animals fed diet D compared with 831 and
935 kJ for animals fed diets B and D, respec-
tively, ad libitum. Uterine weights were 47.5 ±
14.4 mg in animals fed restricted amounts of
diet D compared with 44.4 ± 9.3 and 51.0 ±
6.9 mg for animals fed diets B and D, respec-
tively, ad libitum. This followed the trend
established in Figure 4, but the reduction in
uterine weight for the restricted animals was
not statistically signiﬁcant.
Sexual maturation studies. Rats consum-
ing IF (at 100% concentration) achieved VO
approximately 2 days earlier than those fed
RM1 alone, whereas body weights at VO were
lighter (experiment 7, Table 6) or unaffected
(experiment 8, Table 6; Figure 6). The group
of heavy control animals (experiment 7) was
significantly heavier at VO than were the
“standard” controls, but age at VO was not
different. Age at first and second estrus was
signiﬁcantly reduced by approximately 2 days
for rats consuming IF (experiment 8, Table 6).
No differences in the length of the estrus cycle
were observed between groups.
Animals fed the synthetic diets D and B
had increased body weights (from PND19.5
and 28.5, respectively) when compared with
RM1 controls (data not shown). Rats receiving
RM1 plus DES had reduced body weights
from PND33.5 forward (experiment 9,
Table 7). Consumption of diet D was reduced
from PND26.5 compared with that of the
RM1 controls, whereas consumption of diet B
was similar to that of controls (data not
shown). Compared with the control group fed
RM1, VO occurred 1.3 days earlier in rats fed
diet B and 5.2 days earlier in rats fed diet D
(both advances statistically signiﬁcantly differ-
ent from the RM1 values and from each
other). Body weight at VO for animals fed
diet B was not different from those fed RM1,
but animals fed diet D were significantly
lighter at VO (the difference between diets B
and D was also statistically significant;
Table 7). Cumulative energy intake at the age
of VO gave a consumption of approximately
2,300 kJ/rat at the time of VO for each of the
three diets (Table 7, Figure 6). There was no
statistical difference in energy intake up to the
age of VO across the three diets. The ﬁgure of
approximately 2,300 kJ/rat to day of VO is
similar to the values observed in the IF studies
(Table 7, Figure 6).
DES treatment resulted in an 11.2 day
advance in VO, and the body weight at VO
and the energy intake up to the time of VO
were dramatically reduced (Table 7). DES
intake was calculated to be 5.3 µg/kg/day over
the whole study.
Absolute and adjusted liver and kidney
weights were increased in animals fed diets B
and D. There were no changes in uterine
weights with either synthetic diet (Table 8),
nor were there any organ weight changes after
DES treatment. No organ weight changes
were observed in animals fed IF (data not
shown). The increase in relative liver and kid-
ney weights was observed for AIN-76A previ-
ously (Odum et al. 2001) and has no obvious
explanation.
Discussion
There is a current concern that the diets used
in rodent endocrine toxicity studies may inﬂu-
ence, either qualitatively or quantitatively, the
outcomes of those studies (Ashby et al. 2000;
Boettger-Tong et al. 1998; Casanova et al.
1999; Lawton 2003; Odum et al. 2001;
Owens et al. 2003; Thigpen 1999, 2002,
2003; Tinwell et al. 2000). Most of the studies
cited above have concentrated on the possible
effects of dietary phytoestrogen on rodent sex-
ual maturation, but some studies have also
attempted to evaluate the possible effects of
changes in the ME of the diets (Ashby et al.
2000; Odum et al. 2001; Thigpen et al. 2002;
2003; Tinwell et al. 2000). However, these
attempts have been rendered opaque by the
concomitant effects induced by dietary phyto-
estrogens, failure to monitor food intake
(reliance being placed solely on the stated ME
values of the diets), and the use of proprietary
diets that provide only a narrow range of MEs.
The present studies have overcome these
problems by using synthetic diets devoid of
phytoestrogens—but with a wide range of
ME values—and by monitoring food intake,
leading to accurate assessments of cumulative
energy intake. The soy-based IF was similarly
studied, after establishing that the levels of
phytoestrogen present in it are below those
that affect the sexual maturation end points
evaluated. Our conclusions from this study
are as follows. 
Increasing the ME density of the synthetic
diet increases body weight (Tables 4 and 5,
Figure 3) and total energy intake (Tables 4 and
5, Figure 4) proportionally. Body weight is
increased for diets A–E over 6 days (Figure 3)
and is maintained until PND41 for the two
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Figure 4. The relationship between total energy
intake (kJ/rat) and the ME content (kJ/g) of RM1
and diets A–E between PND19 and PND25 for
groups not receiving ANT in experiment 6 (Table 5).
R2 = 1.00, p < 0.01.
Figure 5. Final body weight (A; –ANT R2 = 0.86, p < 0.05; + ANT: R2 = 0.85, p < 0.05) and absolute (B; –ANT: R2 = 0.82, p < 0.05) and adjusted (C; –ANT: R2 = 0.78,
p < 0.05) uterine weight plotted as a function of increasing total energy intake for animals fed diets A–E over 6 days (experiment 6, Table 5).
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Figure 3. Body weights of female rats fed synthetic
diets with different ME content in the uterotrophic
assay (experiment 6, Table 5). For clarity, groups
receiving ANT and/or DES are not shown.
Statistically significant reductions (p < 0.01 com-
pared with RM1 control) occurred with diet A on
days 2 and 3 and increases occurred with diet B
from day 4 onward and with diets C, D, and E from
day 2 onward.
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■diets evaluated over that period (diets B and D,
Table 7). RM1 diet, which is substantially dif-
ferent in its makeup from diets A–E, produces
a growth curve consistent with its ME being
between that of diets A and B (Figure 3).
Faced with the choice between RM1 diet
and IF solution, rats select the latter, the
strength of the preference being in proportion
to the strength of the IF solution (experi-
ment 2, Table 3). As the IF intake increases, so
also does the total energy intake of the ani-
mals (Table 3). Unlike with the diets,
increased energy intake from drinking IF is
not closely associated with an increase in body
weight. Only in the case of the 200% IF solu-
tion did body weight increase significantly
over 4 days (Table 3), and exposures over
longer periods led to variable effects on body
weight (Table 6).
Increasing energy intake is associated with
an increase in uterine weight for both IF
(Table 3) and the diets A–E (Tables 4 and 5).
In the case of IF, the increase in uterine weight
over the concurrent controls was directly pro-
portional to the percentage of energy intake via
drink (Figure 1). We have shown previously
(Ashby et al. 2000) that the uterotrophic activ-
ity of the IF brand used in this study is shared
by two other proprietary brands of soy-based
IF. We have also shown that rats elect to drink
much less of a cow’s milk–based formula than
they drink soy-based formula (Ashby et al.
2000). Consequently, energy intake through
the cows’ milk–based formula is low (about the
same as 33% IF; Table 3), and only marginal
activity was observed for it in the uterotrophic
assay (Ashby et al. 2000). In the case of the
synthetic diets, the increase in uterine weight
was proportional to the ME of the diets and to
the total energy intake during the experiment
(Tables 4 and 5, Figure 5). The nonresearch
diets RM1 and AIN-76A also gave increases
in uterine weight proportional to their ME
values and total energy intake (Tables 4
and 5). Unlike with IF, body weights of the
animals on the synthetic diets increased pro-
portionally to the ME of the diets (Tables 4
and 5, Figure 5).
The uterotrophic activities of IF and the
diets were abolished by coadministration of the
GnRH antagonist ANT, but the uterotrophic
activity of DES was unaffected (Tables 3–5,
Figure 2). This conﬁrms that the uterotrophic
activity of DES, and by analogy the dietary
phytoestrogens studied by Thigpen et al.
(2003), act directly on the uterus, whereas the
uterotrophic activity of the present synthetic
diets, and IF, is stimulated by their effects on
the hypothalamus. The independence of the
uterotrophic effects from changes in body
weight, discussed above for IF, is shown by the
data in Figure 5 to apply equally to the diets.
Figure 5 establishes that body weight increases
induced by the diets, themselves in proportion
to the ME of the diet, are not affected by
ANT, whereas the concomitant increases in
absolute and adjusted uterine weights are abol-
ished by it. There are, therefore, two discrete
influences at work in this study: increases in
energy intake usually lead to increases in body
weight, and increases in energy intake always
lead to increases in uterine weight. Body
weight is not always a good indicator of energy
balance (the difference between intake and
expenditure). It may be inﬂuenced by differ-
ences in gut contents, particularly when the
nature of the diets is different (e.g., dry matter
digestibility), and by the nature of the body
constituents (body fat has eight times the
energy content of bone-free lean tissue per
gram) (Armitage et al. 1983). Differences in
protein:energy ratio, such as seen in the diets
in this study, can signiﬁcantly affect the rela-
tive deposition of body fat and lean tissue
(Blaxter 1975).
The prepubescent increase in uterine
weight, and the advance in puberty induced by
IF, was instigated by the rats through their vol-
untary drinking of IF in preference to eating
the RM1. When presented with a 6.6% glu-
cose solution (equivalent to the glucose content
of IF), they obtained only approximately 20%
of their energy intake from this solution, and
this was insufﬁcient to increase uterine weight
(Table 3). Likewise, when the glucose solution
was supplemented with 5 mg/kg GEN (the
dose of phytoestrogens ingested by human
infants drinking 100% IF), uterine weights
did not increase significantly (Table 3).
Further, the estimated daidzein and GEN
intake during the sexual maturation study of
IF (Table 6) was approximately 14 mg/kg, lev-
els that are inactive in uterotrophic assays
(Farmakalidis et al. 1985; Kanno et al. 2003a).
The uterotrophic activity of the IF solution is
therefore independent of its sugar content or
its constituent phytoestrogens.
An advance in the day of VO mirrors the
increases in uterine weight observed for ani-
mals maintained on diets B and D (Table 7)
from weaning to PND41. Similar advances in
the day of VO, together with advances in the
day of ﬁrst and second estrus, are seen for ani-
mals exposed to 100% IF from weaning to
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Figure 6. Body weights at VO (A) and cumulative energy consumption from weaning to the mean day of VO
(B) for rats in the female sexual maturation studies (experiments 8 and 9, Tables 6 and 7). Values shown
are mean ± SD.
**p < 0.01 for body weights at VO for diet D (and RM1/DES 30 µg/L drinking water) compared with RM1. #p < 0.01 for body
weights at VO for diet B compared with diet D; there were no statistically signiﬁcant differences in energy intake between
diets RM1 and IF (experiment 8) or RM1 and diets B or D (experiment 9).
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Table 6. Female sexual maturation of rats given IF (experiments 7 and 8).
Cumulative First estrus Second estrus
Body weight Body weight energy intake Age at VO Body weight Age Weight Age Weight
Experiment/treatment at PND21 (g) at PND41 (g) at VOa(KJ) (PND) at VO (g) (PND) (g) (PND) (g) No.
Experiment 7
RM1 48.0 ± 5.6 145.1 ± 15.5 ND 33.7 ± 1.9 111.3 ± 8.5 ND ND ND ND 10
RM1 heavy control  56.5 ± 1.7* 159.5 ± 13.2* ND 33.3 ± 1.5 124.8 ± 12.9* ND ND ND ND 10
RM1/IF 100% 48.0 ± 5.6 164.6 ± 11.8** ND 31.1 ± 1.5** 99.2 ± 12.4* ND ND ND ND 10
Experiment 8
RM1 37.1 ± 5.7 140.7 ± 11.6 2,181 ± 425 34.5 ± 2.0 102.4 ± 13.2 37.1 ± 3.9 115.2 ± 19.8 44.6 ± 5.9 149.6 ± 23.0 45
RM1/IF 100% 37.5 ± 5.7 143.2 ± 14.2 2,249 ± 368 32.4 ± 1.2** 91.5 ± 10.8 35.3 ± 2.7* 108.3 ± 18.7 42.8 ± 5.4* 148.6 ± 28.4 61
ND, not determined. Values shown are mean ± SD. 
aCumulative energy intake was calculated from the amount of IF and food (and their MEs) consumed per rat up to VO. *p < 0.05 and **p < 0.01 compared with RM1 control; there were no
statistically signiﬁcant differences in energy intake at VO between RM1 and IF (experiment 8).PND41 (Table 6). The day of VO for the four
energy sources evaluated (RM1, diets B and D,
and IF) correlates better with total energy
intake up to the day of VO than it does with
body weight on the day of VO (Figure 6).
Supporting the secondary role of body weight
on the day of VO is the fact that preselected
heavy control animals maintained on RM1
have the same day of VO as do normal-weight
control animals maintained on RM1, yet they
have signiﬁcantly heavier body weights at the
day of VO (experiment 7, Table 6).
At the simplest level, these combined data
indicate that events associated with the onset
of puberty in female rats can be accelerated by
increasing energy intake, enabled either by
the use of high-ME diets or by the animals
electing to drink large quantities of the rela-
tively low-energy IF. The two peripubertal
events monitored were the premature growth
of the uterus and the early onset of puberty
(VO and first estrus). These effects may be
mechanistically distinct. The increases in
uterine weight induced (from ~ 20 mg to
~ 40 mg) consistently fall short of the maxi-
mum uterine weight achieved at puberty, or
after pseudoprecocious puberty induced by
DES acting directly on the uterus (~ 130 mg).
This suggests that the food effects are caused
by the hypothalamus maximizing the prepu-
bescent release of estrogens, as opposed to ini-
tiating full puberty. Previous studies (Ashby
et al. 2000) have shown that the IF-induced
uterine weight increase is inhibited by the
estrogen receptor antagonist fulvestrant. This
endogenous release of estrogens may be from
the ovaries, initiated by GnRH acting on the
pituitary-gonad axis via follicle-stimulating
hormone, or from the adrenal glands via
hypothalamic corticotrophin-releasing hor-
mone acting on the pituitary–adrenal axis
(Harvey and Everett 2003). The inhibition of
uterine growth by ANT suggests the former,
consistent with the demonstration by
Branham and Sheehan (1995) that ovari-
ectomy or adrenalectomy of PND6 rats
decreased uterine growth. However, the early
onsets of VO and, in the case of IF, of first
and second estrus provide clear evidence of an
advance in full hypothalamic puberty subse-
quent to achievement of a cumulative energy
intake of approximately 2,300 kJ/rat post-
weaning. Administration of ANT to rats dur-
ing this period results in a total block on
puberty (Ashby et al. 2002), so by deﬁnition,
it was not possible use ANT to prove the
involvement of the hypothalamus in these
energy-induced pubertal effects.
Although there will be small variations in
the efficiency with which the different pro-
portions of dietary fat and carbohydrate in
diets A–E would be converted to body fat, it
is probable that the amount of fat deposited
for any level of energy intake from these diets
would be similar (not determined here). Body
fat is an accurate measure of energy balance
because it integrates the varying and some-
times small daily differences in intake and
expenditure of energy. It is likely, therefore,
that body fat content, rather than energy
intake per se, is the critical variable. However,
body weight does not provide an invariable
indicator of body fat because of differences in
the proportions of individual components of
body weight, such as gut fill, body fat, and
lean tissue—factors that may vary with the
amount and nature of the diet, feeding pat-
tern, and environment.
Earlier studies have failed to demonstrate
clearly the central involvement of cumulative
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Table 7. Female sexual maturation of rats fed synthetic diets (experiment 9).
Cumulative
Body weight Body weight energy intake Age at Body weight
Treatment at PND21 (g) at PND41 (g) at VOa (kJ) VO (PND) at VO (g) No.
RM1 40.9 ± 4.0 137.5 ± 11.9 2,404 ± 108 36.1 ± 1.7 114.2 ± 9.1 20
Diet B 38.3 ± 4.2 147.8 ± 5.4** 2,214 ± 151 34.8 ± 1.5* 117.2 ± 9.9 20
Diet D 43.5 ± 4.1** 166.1 ± 10.6** 2,281 ± 208 30.9 ± 1.0**,# 105.1 ± 8.5**,# 20
RM1/DES 30 µg/L 39.7 ± 3.0 127.1 ± 12.8** 479 ± 58** 24.9 ± 0.7** 55.7 ± 7.4** 10
Values are mean ± SD. DES was administered in the drinking water. 
aTotal energy intake was calculated from the amount of food (and the MEs of the diets) consumed per rat up to VO.
*p < 0.05, **p < 0.01 compared with RM1 control. #p < 0.01 for age and body weight at VO for diets D and B; there were no
statistically signiﬁcant differences in energy intake at VO between RM1 and diets B and D when either RM1 or diet B was
used as the control.
Table 8. Organ weights of female rats (at PND41) fed synthetic diets (experiment 9).
Treatment Liver (g) Kidney (g) Uterus (mg) No.
RM1
Absolute 6.7 ± 0.7 1.2 ± 0.1 177 ± 43 20
Adjusted 7.2 1.3 178
Diet B
Absolute 8.2 ± 0.6** 1.8 ± 0.2** 203 ± 62 20
Adjusted 8.3** 1.8** 203
Diet D
Absolute 9.2 ± 0.9** 1.8 ± 0.2** 205 ± 43 20
Adjusted 8.5** 1.7** 203
RM1/DES (30 µg/L)
Absolute 5.8 ± 1.0 1.1 ± 0.1 188 ± 52 10
Adjusted 6.9 1.29 180
Values shown are mean ± SD. DES was administered in the drinking water.
aOrgan weights adjusted for covariance with terminal body weights. **p < 0.01 compared with RM1 control.
Figure 7. Intake of calories (A), protein (B), and fat (C) per capita from 1961 to 2000. Plotted using data from the database of the Food and Agricultural Organisation
of the United Nations (FAO 2003). 
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energy intake of puberty because of the con-
comitant presence of biologically active doses
of phytoestrogens in the foods (Odum et al.
2001; Thigpen et al. 2002, 2003). It is there-
fore important to be aware of both the phyto-
estrogen content of diets and dietary energy
intake during rodent studies evaluating the
endocrine activities of chemicals. The latter
will involve knowledge of the ME of the diet
and awareness of differences in food intake
between test and control groups.
The present observations relate directly to
chemical safety assessments in rodents.
However, the dramatic and continuing increase
in human energy intake (Figure 7) indicates
that the present observations may have a more
general relevance to human health. For exam-
ple, health breads such as Burgen (advertised as
containing plant estrogens from soy and lin-
seed; Allied Bakeries, Maidenhead, UK) show
similar effects to those described here (Ashby
and Tinwell 1998), and gross energy intake
may also be associated with reports of a reduc-
tion in the age at which human females are
entering puberty (Herman-Giddens et al.
1997). The present observations on IF are also
relevant and are suggested to have the follow-
ing implications for human infants drinking
soy-based IF. First, the phytoestrogen content
of these formulas leads to an average daily
intake of approximately 4.5–10 mg/kg total
phytoestrogens/day [Ministry of Agriculture,
Fisheries and Food (MAFF) 1998; Setchell
et al. 1997]. This level is known from other
experiments to be devoid of reproductive
effects in rodents (Lewis et al. 2003). Second,
the observations made herein relate to the
onset of puberty and are therefore of no rele-
vance to infant humans exposed during the
ﬁrst few years of their life. Third, although the
soy-based IF has the same ME as cows’ milk
formulas, they may be more palatable to
infants than cows’ milk formulas, and this may
lead to excess energy intake, as happened in the
present rodent studies. Anecdotal information
indicates that mothers sometimes allow such
excess intake to induce sleep. The only toxico-
logic implication for human infants is therefore
one of possible excess caloriﬁc/energy intake.
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